Stem Cell Cancer


Cancer When transplanted into an animal host, stem cells (CSCs), a tiny fraction of cells within tumours, are capable of self-renewal, differentiation, and tumorigenicity. To recognise and enrich CSCs, a range of cell surface markers, including CD44, CD24, and CD133, are frequently utilised.

Some cancers, such as leukaemia, lymphoma, and myeloma, can be treated by bone marrow or stem cell transplantation. High dose chemotherapy and occasionally radiotherapy are used to treat them. They may also be referred to as intense treatment, stem cell rescue, or bone marrow rescue. At 20 years after transplantation, the study cohort's estimated survival rate was 80.4% (95% CI, 78.1% to 82.6%). Age at transplantation was inversely linked with survival after five years.


 


  • Chemotherapy
  • Radiotherapy

Related Conference of Stem Cell Cancer

November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands
April 26-27, 2027

26th World Congress on Cancer and Diagnostics

Barcelona, Spain
April 27-28, 2027

37th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2027

7th World Congress on Breast Cancer

Berlin, Germany
May 05-06, 2027

23rd International Conference on Cancer Research

Berlin, Germany

Stem Cell Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in